Logo image
Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes
Journal article   Open access   Peer reviewed

Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes

Jimmy T Efird, Yuk Ming Choi, Stephen W Davies, Sanjay Mehra, Ethan J Anderson and Lalage A Katunga
International journal of environmental research and public health, Vol.11(2), pp.2328-2345
02/21/2014
DOI: 10.3390/ijerph110202328
PMCID: PMC3945602
PMID: 24566057
url
https://doi.org/10.3390/ijerph110202328View
Published (Version of record) Open Access

Abstract

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.
Blood Glucose - drug effects Animals Humans Plant Preparations - pharmacology Plant Preparations - therapeutic use Insulin Resistance Momordica charantia Phytotherapy Prediabetic State - drug therapy Randomized Controlled Trials as Topic

Details

Logo image